Your session is about to expire
← Back to Search
Positive Processes and Transition to Health (PATH) for Post-Traumatic Stress Disorder (PATH Trial)
PATH Trial Summary
This trial will test a new therapy called Positive Processes and Transition to Health (PATH) to see if it helps people with symptoms of PTSD and/or depression. PATH will be given to 45 adults who have experienced a major life event, like the loss of a loved one. The goals of this trial are to see if PATH works and if patients stick with the therapy.
- Post-Traumatic Stress Disorder
- Depression
PATH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PATH Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does the age limit for this medical trial extend beyond eighty-five years old?
"Adhering to this trial's enrollment requirements, the age cut-off is 18 years old as a minimum and 65 as a maximum."
Am I eligible to enroll in this investigatory project?
"To be eligible for consideration, applicants must have a history of stress disorders or trauma and meet the age requirement of 18 to 65. A total of 45 people will be accepted into this clinical trial."
Is it possible to participate in this experiment at the moment?
"Affirmative. According to clinicaltrials.gov, this medical experiment commenced on April 1st 2022 and was revised most recently on April 28th of the same year. 45 participants must be enlisted from 3 distinct clinics in order for the trial to move forward."
How many participants are currently enrolled in this scientific experiment?
"To move this study forward, 45 qualified participants will be required. Those who wish to join can do so through University of Washington in Seattle or the University of Delaware in Newark."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger